Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-21-004506
Filing Date
2021-05-13
Accepted
2021-05-13 16:00:56
Documents
75
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 400423
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 5149
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 5554
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3625
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 3817
  Complete submission text file 0001062993-21-004506.txt   3686760

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY INSTANCE DOCUMENT igxt-20210331.xml EX-101.INS 511357
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igxt-20210331.xsd EX-101.SCH 65614
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igxt-20210331_cal.xml EX-101.CAL 37543
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igxt-20210331_def.xml EX-101.DEF 135581
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igxt-20210331_lab.xml EX-101.LAB 678604
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igxt-20210331_pre.xml EX-101.PRE 273289
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Filer) CIK: 0001098880 (see all company filings)

EIN.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31187 | Film No.: 21919453
SIC: 2834 Pharmaceutical Preparations